Day Two at TCT and Avertix is going strong. Booth #3118 to learn about the Guardian! #TCT2024 #CardioInnovations
Avertix Medical
Medical Equipment Manufacturing
First and only FDA-Approved Implantable Cardiac Surveillance System | A New Day Dawns for Heart Attack Survivors and ACD
About us
Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we’re dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix’s Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.
- Website
-
www.avertix.com
External link for Avertix Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Type
- Privately Held
- Founded
- 2001
Locations
-
Primary
Get directions
-
Get directions
40 Christopher Way
Eatontown, New Jersey 07724, US
Employees at Avertix Medical
Updates
-
Please stop by booth #3118 at TCT to discuss what a Guardian Program can do for your institution! #CardioInnovations #TCT2024 #AdvancingCardiology
-
-
Join us for the Oklahoma Heart Guardian Experience, a premier gathering of healthcare leaders dedicated to advancing medical innovation and improving patient care. #symposium #futureofmedicine #MedSymposium2024
-
-
Avertix Medical reposted this
Meet Dr. Naeem Tahirkheli! He works on the peripheral vascular systems to improve health and quality of life for all his patients. Get to know more about his work in interventional cardiology. Oklahoma Heart Hospital is proudly physician-owned.
-
Avertix Medical reposted this
Excited to share that the Medical University of South Carolina in Columbia has completed the city’s first Guardian Implant! It has been a pleasure working with their amazing team to make this milestone possible. Huge congratulations to L. Garrison Morgan, MD, FACC, FSCAI, Princilla Roberts, Dr. John Sutton and team! Avertix Medical
-
-
Ahmad Sherif Gharib Lead Auditor, Trainer and Technical Reviewer — FSSC 22000 | BRCGS | ISO/IEC 17025 | ISO 13485 | CE Mark 35m I recently had the opportunity to conduct a successful ISO 13485:2016 audit remotely on Avertix Medical on behalf of Brilliant Certification, and I want to extend my sincere thanks to the entire team for their cooperation and professionalism throughout the process. The team at Avertix Medical was well-prepared, and their commitment to maintaining a robust Quality Management System was evident at every step. It’s always a pleasure to work with organizations that are dedicated to upholding high standards in the medical device industry. A special thanks to Dave Keenan, and everyone who facilitated the audit and provided the necessary information promptly and transparently. Your efforts made the audit process both efficient and effective. Looking forward to continuing to work with organizations striving for excellence in quality and compliance.
-
-
What an incredible time at #SCAI2024 in Long Beach! @Dr. Faraz shared insightful data from the ALERTS Trial on the importance of early, rapid ACS detection in high-risk patients. Can't wait to see everyone again next year! #Avertix #GUARDIAN #medtech #cardiology
Director of Interventional Cardiology at Hackensack University Medical Center Hackensack Meridian Health
Proud to share that I presented data on the ALERTS trial at the SCAI'24 scientific sessions. The trial showed that "20 Minute ST SEGMENT CHANGES" can serve as a higher confidence marker for 80-90% coronary stenosis. This is a critical finding that can help improve patient outcomes in high-risk cases. Looking forward to collaborating with the Avertix team on the importance of intracardiac EKG monitoring in high-risk patients for recurrent AMI. Early recognition and treatment are crucial for saving lives, and I'm excited to work towards this goal together. #ALERTSTrial #SCAI24 #cardiology #healthcare #medicalresearch #AVERTIX #hackensackuniversitymedicalcenterHMH
-
-
Avertix Medical reposted this
Director of Interventional Cardiology at Hackensack University Medical Center Hackensack Meridian Health
Proud to share that I presented data on the ALERTS trial at the SCAI'24 scientific sessions. The trial showed that "20 Minute ST SEGMENT CHANGES" can serve as a higher confidence marker for 80-90% coronary stenosis. This is a critical finding that can help improve patient outcomes in high-risk cases. Looking forward to collaborating with the Avertix team on the importance of intracardiac EKG monitoring in high-risk patients for recurrent AMI. Early recognition and treatment are crucial for saving lives, and I'm excited to work towards this goal together. #ALERTSTrial #SCAI24 #cardiology #healthcare #medicalresearch #AVERTIX #hackensackuniversitymedicalcenterHMH
-